Colinz Laboratories Share Price

Colinz Laboratories

CMP as on22-Jan-21 13:42

₹ 10.70
0.08 0.75%

Open

₹ 10.62

Turnover (lac)

Prev. Close

₹ 10.62

Day's Vol (shares)

₹ 1,347

Day's Range

₹ 10.62
₹ 10.70

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 15-Oct-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2020 ,inter alia, to consider and approve THIS TO INFORM YOU THAT THE PURSUANT TO SEBI REGULATION 29(2) OF (LODR), REGULATIONS, 2015. ID SCHEDULED TO BE HELD ON 31-10-2020 AT THE REGISTERED OFFICE OF THE COMPANY. AT 3.30 PM We would like to inform you that , the Board of Directors of the Company at their meeting held today i.e. 31st October, 2020 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS ) for the quarter and half year ended on 30th September, 2020
Board Meeting - 05-Aug-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2020 ,inter alia, to consider and approve 1. To Approve Unaudited Financial Results for the Quarter Ended, 30th June, 2020. 2. To approve Directors Report for the year ended as on 31st March, 2020. 3. To approve Management discussion, Corporate Governance report, CEOs certification & other documents, if any. 4. To take note of Secretarial Audit Report issued by M/s. Sanjay Dholakia & Associates, Practicing Company Secretaries for the financial year ended 31st March, 2020. 5. To Decide the Date, time, venue and mode of Annual General Meeting and Approve Notice of AGM. 6. To Fix dates of Book Closure & Record Date. 7. To consider & approve Appointment of M/s. Sanjay Dholakia & Associates, Practicing Company Secretaries as the Secretarial Auditor for the financial year ended 31st March, 2021. 8. To grant authority to file relevant Forms with MCA w.r.t forthcoming AGM 9. To take note of the entries in the Statutory Register. 10. To consider any other business with the permission of Chair. The Board approved the agenda as per the intimation given to BSE on 14-08-2020 as per the outcome attached (As Per BSE Announcement Dated on 14/08/2020)
Board Meeting - 17-Jun-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Tuesday, 30th June, 2020 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, at 2.30 p.m. inter-alia to transact following businesses- 1. To discuss about impact of COVID-19 pandemic and the effect of lockdown on the operations of the Company. 2. To consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended 31st March, 2020 In terms of provision of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors, at its Meeting held today, i.e., 30th June 2020, discussed and/or approved the following - a) The Board discussed about the impact of COVID-19 pandemic and the effect of lockdown on the operations of the Company. b) The Board approved Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (Ind- AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2020; (As per BSE Announcement Dated on 30/06/2020)
Board Meeting - 14-Jan-2020 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2020 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Friday, 31st January, 2020, at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, at 1.30 p.m. inter-alia to consider, approve and take on record the Un- audited Financial Results (IND-AS) of the Company for the quarter and nine months ended 31st December,2019. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed for the Promoters/Directors /Officers/Designated Employees including immediate relatives of the Company till 48 hours after announcement of financial results to the public, i.e. till 2nd February, 2020. We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2020 has, inter alia considered and unanimously; 1) approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2019. 2) Limited Review Report received from M/s. Vora & Associates, Chartered Accountants, the Statutory Auditors of the Company. The Meeting commenced at 3.30 p.m. and concluded at 5.00 p.m. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31st January, 2020 with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2019 (As Per BSE Announcement Dated 31.01.2020) Please find enclosed herewith Newspaper Clippings of Un-audited Financial Results for the quarter and nine months ended on 31st December, 2019 published in FREE PRESS JOURNAL and NAVSHAKTI on 1ST February,2020 in pursuance of Regulation 47(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which were approved in the Board meeting held on 31st January, 2020. (As Per BSE Announcement Dated 01.02.2020)